Editas Medicine (EDIT)
2.73
-0.05 (1.80%)
Upcoming Events
Latest Headlines
Form 144 Editas Medicine, Inc. Filed by: Burkly Linda
July 21, 2026 4:37 PM - SEC Filing
Form 4 Editas Medicine, Inc. For: Jun 17 Filed by: Connaughton Bernadette
June 22, 2026 4:32 PM - SEC Filing
Form 4 Editas Medicine, Inc. For: Jun 17 Filed by: Hopfield Jessica
June 22, 2026 4:31 PM - SEC Filing
Form 4 Editas Medicine, Inc. For: Jun 17 Filed by: Hirsch Andrew
June 22, 2026 4:30 PM - SEC Filing
Form 4 Editas Medicine, Inc. For: Jun 17 Filed by: Scadden David
June 22, 2026 4:30 PM - SEC Filing
Form 4 Editas Medicine, Inc. For: Jun 17 Filed by: Levy Elliott M.
June 22, 2026 4:29 PM - SEC Filing
Form 8-K Editas Medicine, Inc. For: Jun 17
June 18, 2026 4:29 PM - SEC Filing
Form 4 Editas Medicine, Inc. For: Jun 03 Filed by: Parison Amy
June 5, 2026 4:33 PM - SEC Filing
Form 4 Editas Medicine, Inc. For: Jun 03 Filed by: O'Neill Gilmore Neil
June 5, 2026 4:33 PM - SEC Filing
Form 4 Editas Medicine, Inc. For: Jun 03 Filed by: Burkly Linda
June 5, 2026 4:32 PM - SEC Filing
Form SCHEDULE 13G Editas Medicine, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
June 3, 2026 4:46 PM - SEC Filing
Form SCHEDULE 13G Editas Medicine, Inc. Filed by: TCG Crossover GP III, LLC
June 3, 2026 4:17 PM - SEC Filing
Form SCHEDULE 13G Editas Medicine, Inc. Filed by: Commodore Capital LP
June 2, 2026 5:32 PM - SEC Filing
Form 144 Editas Medicine, Inc. Filed by: O'Neill Gilmore Neil
May 29, 2026 4:40 PM - SEC Filing
Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference
May 28, 2026 4:01 PM - StreetInsider
Increasing unusual option volume: CRSR NASA APPS EDIT AMPG MRLN AOSL EMN BEAM
May 27, 2026 10:14 AM - StreetInsider
Form 424B5 Editas Medicine, Inc.
May 26, 2026 5:31 PM - SEC Filing
Form 8-K Editas Medicine, Inc. For: May 26
May 26, 2026 4:43 PM - SEC Filing
Editas Medicine prices $125 million public offering of stock and warrants
May 26, 2026 9:05 AM - StreetInsider
Editas Medicine Announces Pricing of Up to $319.4 Million Public Offering
May 26, 2026 9:05 AM - StreetInsider
Form S-3MEF Editas Medicine, Inc.
May 26, 2026 8:36 AM - SEC Filing
Form 8-K Editas Medicine, Inc. For: May 26
May 26, 2026 8:07 AM - SEC Filing
Form 424B5 Editas Medicine, Inc.
May 26, 2026 6:27 AM - SEC Filing
Editas Medicine announces public offering of stock and warrants
May 26, 2026 6:15 AM - StreetInsider
Editas Medicine Announces Proposed Public Offering
May 26, 2026 6:15 AM - Globe NewsWire
Form 8-K Editas Medicine, Inc. For: May 25
May 26, 2026 6:10 AM - SEC Filing
Editas Medicine reports 90% cholesterol reductions in primate study
May 26, 2026 6:01 AM - StreetInsider
Editas Medicine Presents EDIT-401 Preclinical Data Demonstrating Robust Reductions in LDL-C, Lp(a), and ApoB in Non-Human Primates at the 94th European Atherosclerosis Society Congress
May 26, 2026 6:01 AM - StreetInsider
Form 8-K Editas Medicine, Inc. For: May 14
May 14, 2026 6:16 AM - SEC Filing
Editas Medicine shares new data on EDIT-401 cholesterol treatment
May 14, 2026 6:01 AM - StreetInsider
Editas Medicine Reports New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at the American Society of Gene and Cell Therapy 2026 Annual Meeting
May 14, 2026 6:01 AM - Globe NewsWire
Form 10-Q Editas Medicine, Inc. For: Mar 31
May 5, 2026 4:18 PM - SEC Filing
Form 8-K Editas Medicine, Inc. For: May 05
May 5, 2026 7:03 AM - SEC Filing
Editas Medicine Announces First Quarter 2026 Results and Business Updates
May 5, 2026 7:00 AM - Globe NewsWire
Form ARS Editas Medicine, Inc. For: Apr 28
April 28, 2026 4:39 PM - SEC Filing
Form DEFA14A Editas Medicine, Inc.
April 28, 2026 4:37 PM - SEC Filing
Form DEF 14A Editas Medicine, Inc. For: Apr 28
April 28, 2026 4:35 PM - SEC Filing
Editas Medicine to present EDIT-401 data at scientific conferences
April 27, 2026 4:31 PM - StreetInsider
Editas Medicine to Present New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at Upcoming Scientific Conferences
April 27, 2026 4:31 PM - Globe NewsWire
Full Article List